Literature DB >> 4970562

Tacaribe virus infection of guinea-pig. Virus distribution, appearance of antibodies and immunity against Junin virus infection.

C E Coto, E Rey, A S Parodi.   

Abstract

Entities:  

Mesh：

Year:  1967        PMID： 4970562     DOI： 10.1007/BF01245771

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  5 in total

1.  [IMMUNIZATION OF GUINEA PIGS AGAINST THE JUNIN VIRUS BY INOCULATION WITH TACARIBE VIRUS].

Authors:  A S PARODI; C E COTO
Journal:  Medicina (B Aires)       Date:  1964 May-Jun       Impact factor: 0.653

2.  VIRUS ISOLATIONS FROM HUMAN CASES OF HEMORRHAGIC FEVER IN BOLIVIA.

Authors:  K M JOHNSON; N H WIEBENGA; R B MACKENZIE; M L KUNS; N M TAURASO; A SHELOKOV; P A WEBB; G JUSTINES; H K BEYE
Journal:  Proc Soc Exp Biol Med       Date:  1965-01

3.  PROTECTION AGAINST JUNIN VIRUS BY IMMUNIZATION WITH LIVE TACARIBE VIRUS.

Authors:  N TAURASO; A SHELOKOV
Journal:  Proc Soc Exp Biol Med       Date:  1965-07

4.  [Experimental hemorrhagic fever in the guinea pig (Junin virus)].

Authors:  M C BOXACA; A S PARODI; H RUGIERO; R BLAY
Journal:  Rev Soc Argent Biol       Date:  1961 Aug-Sep

5.  Acetone-ether extracted antigens for complement-fixation with certain neurotropic viruses.

Authors:  J CASALS
Journal:  Proc Soc Exp Biol Med       Date:  1949-02
  5 in total
  4 in total

1.  Status of arenavirus vaccines and their application.

Authors:  K M Johnson
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

2.  Experimental biology and pathogenesis of Junin virus infection in animals and man.

Authors:  M C Weissenbacher; L B de Guerrero; M C Boxaca
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

3.  Cross-protection in nonhuman primates against Argentine hemorrhagic fever.

Authors:  M C Weissenbacher; C E Coto; M A Calello; S N Rondinone; E B Damonte; M J Frigerio
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

Review 4.  Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials.

Authors:  Stephan Olschläger; Lukas Flatz
Journal:  PLoS Pathog       Date:  2013-04-11       Impact factor: 6.823
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.